Who owns KAIROS PHARMA LTD?
- Ticker: KAPA
- CUSIP Number: 48301n104
Tip: Access positions for across all investors
Analyze quarterly positions in Kairos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kairos Pharma stock
Who bought or sold KAIROS PHARMA LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 322k | $228k | 100% | Dec 2025 |
|
| Vanguard Group | 132k | $94k | 0% | Dec 2025 |
|
| Two Sigma Investments | 94k | $67k | 105% | Dec 2025 |
|
| Geode Capital Management | 73k | $52k | 11% | Dec 2025 |
|
| XTX Topco | 49k | $34k | 291% | Dec 2025 |
|
| SevenBridge Financial | 44k | $32k | 0% | Dec 2025 |
|
| Aptus Capital Advisors | 44k | $31k | 0% | Dec 2025 |
|
| State Street Corporation | 24k | $17k | 0% | Dec 2025 |
|
| Hrt Financial | 21k | $15k | 100% | Dec 2025 |
|
| Virtu Financial | 20k | $14k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 15k | $11k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 13k | $9.3k | 100% | Dec 2025 |
|
| Tower Research Capital | 4.2k | $3.0k | -29% | Dec 2025 |
|
Who sold out of Kairos Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Sep 2025 | 25k | $29k |
| FNY Investment Advisers | Sep 2025 | 24k | $27k |
| UBS Group | Sep 2025 | 6.0k | $7.0k |